Multi Column Chromatography: Number of Columns Required for Optimizing Capacity and Productivity
Xhorxhi Gjoka, Mark Allen Pagkaliwangan, Jonathan Hummel, Aditya Utturkar, Rene Gantier, Mark Schofield
Over the last decade, advances in the upstream processing of monoclonal antibodies have resulted in higher bioreactor titers. With increasing titers, the production burden has shifted to downstream processing. Hence, the biopharmaceutical industry has reached a tipping point where the need for higher throughput in downstream processing is leading to the adoption of more efficient multi-column continuous counter-current chromatography systems capable of significantly reducing consumable cost.
In this study, the Protein A mAb capture process is modeled with a focus on the benefits of multi-column chromatography vs. single column (batch) operation. Here we explore the relationship between operating binding capacity (g mAb/L sorbent), residence-time, productivity (g/L/Hr), and the total number of columns required for optimal operation across a range of feed titers (2 g/L, 5 g/L, and 9 g/L).
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
If you don’t have an account you can:
REGISTER NOW – it’s FREE and always will be!
You will benefit from:
- Unlimited access to ALL articles including White Papers
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login as a Guest or via Social Media
This will allow you to read this article but you will only have limited access to The Medicine Maker.Login as Guest Facebook Google+ LinkedIn Twitter